Skip to main navigation
follow
#navigation
Skip to main content
follow
#content
Skip to Footer
follow
#footer
Investors
follow
https://investor.ironwoodpharma.com
Media
follow
https://www.ironwoodpharma.com/media/
Contact Us
follow
https://www.ironwoodpharma.com/contact-us/
LinkedIn
follow
https://www.linkedin.com/company/ironwood-pharmaceuticals/
Twitter
follow
https://twitter.com/ironwoodpharma
Our Company
follow
https://www.ironwoodpharma.com/about/
Our Values
follow
https://www.ironwoodpharma.com/about/values/
Our Executive Team
follow
https://www.ironwoodpharma.com/about/executive-team/
Our Board of Directors
follow
https://www.ironwoodpharma.com/about/board-of-directors/
Open Payments and Transparency
follow
https://www.ironwoodpharma.com/about/open-payments-and-transparency/
Our Product
follow
https://www.ironwoodpharma.com/products/
Discovery of Linaclotide
follow
https://www.ironwoodpharma.com/products/discovery-of-linaclotide/
Our Pipeline
follow
https://www.ironwoodpharma.com/pipeline/
Partnerships
follow
https://www.ironwoodpharma.com/partnerships/
Patients
follow
https://www.ironwoodpharma.com/patients/
Join Us
follow
https://www.ironwoodpharma.com/join-us/
Open Positions
follow
https://www.ironwoodpharma.com/join-us/open-positions/
Internships, Co-ops and Fellowships
follow
https://www.ironwoodpharma.com/join-us/internships-coops-and-fellowships/
Things You Should Know
follow
https://www.ironwoodpharma.com/join-us/hr-policies/
LinkedIn
follow
https://www.linkedin.com/company/ironwood-pharmaceuticals/
Twitter
follow
https://twitter.com/ironwoodpharma
Our Company
follow
https://www.ironwoodpharma.com/about/
Our Values
follow
https://www.ironwoodpharma.com/about/values/
Our Executive Team
follow
https://www.ironwoodpharma.com/about/executive-team/
Our Board of Directors
follow
https://www.ironwoodpharma.com/about/board-of-directors/
Open Payments and Transparency
follow
https://www.ironwoodpharma.com/about/open-payments-and-transparency/
Our Product
follow
https://www.ironwoodpharma.com/products/
Discovery of Linaclotide
follow
https://www.ironwoodpharma.com/products/discovery-of-linaclotide/
Our Pipeline
follow
https://www.ironwoodpharma.com/pipeline/
Partnerships
follow
https://www.ironwoodpharma.com/partnerships/
Patients
follow
https://www.ironwoodpharma.com/patients/
Investors
follow
https://investor.ironwoodpharma.com
Events & Presentations
follow
https://investor.ironwoodpharma.com/events-and-presentations/default.aspx
Corporate Governance
follow
https://investor.ironwoodpharma.com/corporate-governance/governance-documents/default.aspx
Financial Information
follow
https://investor.ironwoodpharma.com/financial-information/quarterly-results/default.aspx
Stock Information
follow
https://investor.ironwoodpharma.com/stock-information/stock-quote-and-chart/default.aspx
Investor FAQ
follow
https://investor.ironwoodpharma.com/investor-faqs/default.aspx
Press Releases
follow
https://investor.ironwoodpharma.com/press-releases/default.aspx
Investor Contacts
follow
https://investor.ironwoodpharma.com/investor-contacts/default.aspx
Join Us
follow
https://www.ironwoodpharma.com/join-us/
Open Positions
follow
https://www.ironwoodpharma.com/join-us/open-positions/
Internships, Co-ops and Fellowships
follow
https://www.ironwoodpharma.com/join-us/internships-coops-and-fellowships/
Things You Should Know
follow
https://www.ironwoodpharma.com/join-us/hr-policies/
Media
follow
https://www.ironwoodpharma.com/media/
More than 90% of Surveyed IBS-C Patients Who Had an ER Visit or Hospitalization in the Past Year Identified Abdominal Pain as a Symptom That Led to the Visit, According to Data Announced by Ironwood Pharmaceuticals at ACG 2021
follow
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/More-than-90-of-Surveyed-IBS-C-Patients-Who-Had-an-ER-Visit-or-Hospitalization-in-the-Past-Year-Identified-Abdominal-Pain-as-a-Symptom-That-Led-to-the-Visit-According-to-Data-Announced-by-Ironwood-Pharmaceuticals-at-ACG-2021/default.aspx
Ironwood Pharmaceuticals to Host Third Quarter 2021 Investor Update Call
follow
https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2021-Investor-Update-Call/default.aspx
Learn About Our Pipeline
follow
/pipeline/
Interested in Joining Our Team?
follow
/join-us/
Our Company
follow
https://www.ironwoodpharma.com/about/
Our Values
follow
https://www.ironwoodpharma.com/about/values/
Our Executive Team
follow
https://www.ironwoodpharma.com/about/executive-team/
Our Board of Directors
follow
https://www.ironwoodpharma.com/about/board-of-directors/
Open Payments and Transparency
follow
https://www.ironwoodpharma.com/about/open-payments-and-transparency/
Our Product
follow
https://www.ironwoodpharma.com/products/
Discovery of Linaclotide
follow
https://www.ironwoodpharma.com/products/discovery-of-linaclotide/
Report a possible side effect
follow
https://www.allergan.com/products/drug-safety
Our Pipeline
follow
https://www.ironwoodpharma.com/pipeline/
Partnerships
follow
https://www.ironwoodpharma.com/partnerships/
Patients
follow
https://www.ironwoodpharma.com/patients/
Join Us
follow
https://www.ironwoodpharma.com/join-us/
Open Positions
follow
https://www.ironwoodpharma.com/join-us/open-positions/
Internships, Co-ops and Fellowships
follow
https://www.ironwoodpharma.com/join-us/internships-coops-and-fellowships/
Things You Should Know
follow
https://www.ironwoodpharma.com/join-us/hr-policies/
Investors
follow
https://investor.ironwoodpharma.com/
Events & Presentations
follow
https://investor.ironwoodpharma.com/events-and-presentations/default.aspx
Corporate Governance
follow
https://investor.ironwoodpharma.com/corporate-governance/governance-documents/default.aspx
Financial Information
follow
https://investor.ironwoodpharma.com/financial-information/quarterly-results/default.aspx
Stock Information
follow
https://investor.ironwoodpharma.com/stock-information/stock-quote-and-chart/default.aspx
Investor FAQ
follow
https://investor.ironwoodpharma.com/investor-faqs/default.aspx
Press Releases
follow
https://investor.ironwoodpharma.com/press-releases/default.aspx
Investor Contacts
follow
https://investor.ironwoodpharma.com/investor-contacts/default.aspx
Media
follow
https://www.ironwoodpharma.com/media/
Contact Us
follow
https://www.ironwoodpharma.com/contact-us/
LinkedIn
follow
https://www.linkedin.com/company/ironwood-pharmaceuticals/
Twitter
follow
https://twitter.com/ironwoodpharma
Privacy Policy
follow
https://www.ironwoodpharma.com/privacy-policy/
Terms of Use
follow
https://www.ironwoodpharma.com/terms-of-use/
California Privacy Policy
follow
https://www.ironwoodpharma.com/california-privacy-policy/
Site Map
follow
https://www.ironwoodpharma.com/site-map/
Contact Us
follow
https://www.ironwoodpharma.com/contact-us/
Cookie Policy
follow
/wp-content/uploads/2020/12/IPI-BCP-092-Cookie-Policy.pdf
follow
javascript:void(0);